Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

ClinicalTrials.gov ID: NCT00676507

Public ClinicalTrials.gov record NCT00676507. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Study of Lucanix™ (Belagenpumatucel-L) in Advanced Non-small Cell Lung Cancer: An International Multicenter, Randomized, Double-blinded, Placebo-controlled Study of Lucanix™ Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Regimen of Front-line, Platinum-based Combination Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Rationale: Vaccines made from gene-modified tumor cells may help the body build an immune response to kill tumor cells. It is not yet known whether vaccine therapy is more effective than a placebo as maintenance therapy in treatment of subjects with non-small cell lung cancer. Purpose: This randomized phase III trial is studying vaccine therapy to see how well it works compared with a placebo in treating subjects with stage III or stage IV non-small cell lung cancer.

Study identification

NCT ID
NCT00676507
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovaRx Corporation
Industry
Enrollment
532 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2008 (Type not available)
Primary completion
Jan 2013 (Actual)
Completion
Jan 2013 (Actual)
Last update posted
May 8, 2015

2008 – 2013

United States locations

U.S. sites
53
U.S. states
29
U.S. cities
49
Facility City State ZIP Site status
Southern Cancer Center Mobile Alabama 36608 —
Alaska Regional Hospital Anchorage Alaska 99508 —
Mayo Clinic Cancer Center Scottsdale Arizona 85259 —
Clopton Clinic Hematology/Oncology Jonesboro Arkansas 72401 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
University of California, San Diego La Jolla California 92093 —
UCLA Pasadena Oncology Pasadena California 91105 —
Cancer Care Associates Redondo California 90277 —
Innovative Research Center of California San Diego California 92103 —
Sansum Clinic Santa Barbara California 93105 —
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105 —
Central Coast Medical Oncology Corporation Santa Maria California 93454 —
UCLA Cancer Center Santa Monica California 90404 —
UCLA Cancer Center-Valencia Valencia California 91355 —
UCLA Cancer Center Westlake Village California 91361 —
University of Colorado Health Science Center Aurora Colorado 80045 —
Pasco Hernando Oncology Associates, P.A. Brooksville Florida 34613 —
Medical Specialist of Palm Beaches Lake Worth Florida 33467 —
Ocala Oncology Ocala Florida 34471 —
Space Coast Medical Center Titusville Florida 32796 —
Atlanta Cancer Care Roswell Georgia 30076 —
Kootenai Cancer Center Coeur d'Alene Idaho 83814q —
St. Francis Medical Group Oncology and Hematology Specialists Indianapolis Indiana 46237 —
Iowa Blood and Cancer Center Cedar Rapids Iowa 52402 —
James Graham Brown Cancer Center Louisville Kentucky 40202 —
Hematology Oncology Life Center Alexandria Louisiana 71301 —
National Cancer Institute Center for Cancer Research, Medical Oncology Branch Bethesda Maryland 20892-1182 —
Henry Ford Health System Detroit Michigan 48202 —
University of Minnesota Medical Center Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
University of Tennessee Cancer Institute Southaven Mississippi 38671 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
Richmond University Medical Center Staten Island New York 10310 —
Eastchester Center for Cancer Care The Bronx New York 10469 —
Allergy Partners of West North Carolina Asheville North Carolina 28801 —
Cancer Care of WNC Asheville North Carolina 28801 —
Gabrail Cancer Center Research LLC Canton Ohio 44718 —
Optim Oncology Midwest City Oklahoma 73110 —
Cancer Center of the Carolinas Greenville South Carolina 29605 —
University of Tennessee Cancer Institute Bartlett Tennessee 38133 —
University of Tennessee Cancer Institute Germantown Tennessee 38138 —
University of Tennessee Cancer Institute Memphis Tennessee 38104 —
Texas Cancer Center Abilene, Texas Oncology P.A. Abilene Texas 79606 —
Mary Crowley Cancer Research Centers Dallas Texas 75230 —
Allison Cancer Center, Texas Oncology, P.A. Midland Texas 79701 —
Tyler Cancer Center, Texas Oncology Tyler Texas 75702 —
Seattle Cancer Care Alliance/Fred Hutchinson Cancer Res Ctr/Univ. of Washington Med Ctr Seattle Washington 98109 —
Davis Memorial Cancer Care Center Elkins West Virginia 26241 —
Marshfield Clinic Weston Center Weston Wisconsin 54476 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00676507, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00676507 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →